Registrador and Regente Sanitario: Who May File in Nicaragua
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Nicaragua grants filing capacity to a person, not to a company. Applications for product sanitary registration must be handled by professionals in the fields of medical sciences and electronic medicine, holding a código sanitario issued by ANRS and acting under a power approved by SAJ (NTON 24001:2023, Chapter 5, Articles 5 and 9). Applications for a sanitary licence must be handled by the establishment’s regente sanitario or by a professional nominated as regente (RA 0007/2025, Anexo I, Article 5 item a). Both categories of professional need a Karplus account, and the account is requested through the official application form addressed to dismed@minsa.gob.ni. The distinction matters because the two roles sit on different regulatory tracks and are not interchangeable, even where one individual happens to hold both.
- Product registration is filed by a registrador holding a código sanitario (Chapter 5, Articles 5 and 9).
- Sanitary licences are filed by the establishment’s regente sanitario or a nominated regente (RA 0007/2025, Anexo I, Article 5 item a).
- The código sanitario belongs to the individual, not the company.
- The filing power must be approved by SAJ (Chapter 6, item 5).
- Karplus accounts are personal and cannot be lent (Anexo I, Article 5 item i).
- Volume is capped twice: five submissions per day and 25 powers per registrador.
2. Legal basis
The rules are split between the technical standard, which defines who may file and under what authority, and the administrative resolution, which defines the operating rules of the platform through which filing now happens.
| Technical standard | NTON 24001:2023, Tecnología de la salud. Dispositivos médicos. Requisitos para el Registro Sanitario (La Gaceta No. 192, 21 October 2024) | Chapter 5, Article 5 | Under the regulations to Ley 423, registration must be handled by professionals in medical sciences and electronic medicine holding a código sanitario issued by ANRS |
| Technical standard | NTON 24001:2023 | Chapter 5, Article 9 | The professional handling the registration must be appointed by the legal manufacturer or its designee by letter or power of attorney, approved by DDM |
| Administrative resolution | Resolución Administrativa N° 0007/2025 (effective 2 May 2025) | Anexo I, Article 5 item a | Sanitary licence applications may be handled only by the establishment’s regente sanitario or a professional nominated as regente |
| Administrative resolution | Resolución Administrativa N° 0007/2025 (effective 2 May 2025) | Anexo I, Article 5 item e | Registration must be handled by a health sciences professional holding an SAJ-approved power |
| Administrative resolution | Resolución Administrativa N° 0007/2025 (effective 2 May 2025) | Anexo I, Article 5 items f and g, Article 6 | A Karplus account is required; the account is requested on the official form to dismed@minsa.gob.ni, and existing accounts activate the device module |
| Technical standard | NTON 24001:2023 | Chapter 6, item 2 l | The applicant field of the official form records name, identity number, address, telephone, email and código sanitario |
3. Expert insights
Insight one: the two roles sit on two different tracks. The registrador handles product registration; the regente sanitario handles the sanitary licence of the operating establishment. In one company the two roles may be held by different individuals, or by the same person — the account application form in Anexo II of RA 0007/2025 allows both «REGENTE SANITARIO» and «REGISTRADOR» to be ticked.
Insight two: the código sanitario belongs to the individual. It is a number issued by ANRS to a person, not to an enterprise. What the enterprise holds is the fact that a named person holds that number. Staff turnover therefore changes filing capacity directly; it is not an asset that can be handed over internally.
Insight three: the appointment needs SAJ approval. Chapter 5, Article 9 states «estar acreditados por el fabricante legal o quien este designe, mediante carta de autorización o a través de poder aprobados por la Dirección de Dispositivos Médicos». A letter of appointment or a power of attorney will do, but either must be approved by DDM, and Chapter 6, item 5 carries that into the registration file.
Insight four: three hard constraints attach to Karplus. The account cannot be lent (Anexo I, Article 5 item i), no more than five submissions may be made per day (item l), and no new submission may be lodged while the same registration or establishment is still in progress (item m). Filing capacity is personal, and it cannot be multiplied by sharing accounts.
Insight five: the 25-power cap operates on another axis. RA 0001/2026 limits each registrador to 25 powers, with one registrador per 25 powers held by a legal person. That rule constrains the total stock of authorisations, while the Karplus rule constrains daily throughput; the two are not interchangeable.
Insight six: three records must agree. The applicant name and código sanitario in field l of the registration form, the same set of data in the Karplus account application (Anexo II), and the SAJ-approved filing power (Chapter 6, item 5) have to match. Where they do not, the file is returned at the pre-assessment stage.
4. Practical recommendations
- Name the filer for each track: a registrador for product registration, a regente sanitario for the operating licence; both boxes may be ticked on the Anexo II form.
- Verify who actually holds the código sanitario, and prepare a replacement plan before any staff change.
- Obtain SAJ approval for the filing power under Chapter 6, item 5, using either a letter of appointment or a power of attorney.
- Manage the account under Article 5 item i: never lent, with a written record of any handover.
- Plan volume on both axes: no more than five submissions a day, no more than 25 powers per registrador.
- Cross-check the three records — field l, the Karplus account form, and the SAJ-approved power — before submission.
5. Verification checklist
- □ A filer has been named for each track, product registration and operating licence
- □ The individual holding the código sanitario has been verified, with a replacement plan for staff changes
- □ The filing power has been approved by SAJ under Chapter 6, item 5
- □ The Karplus account is held personally, has not been lent, and any handover is documented
- □ Filing volume has been checked against five submissions per day and 25 powers per registrador
- □ Field l, the account application and the SAJ-approved power have been checked for consistency
Regulatory information verified as of 29 October 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us